Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 494, pseudogene** (RNU6-494P) is a genomic pseudogene that derives from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA itself is a highly conserved non-coding RNA that functions as an essential component of the spliceosome, the cellular machinery responsible for pre-mRNA splicing in eukaryotes[3][1]. However, *pseudogenes* like RNU6-494P are generally regarded as genomic sequences that resemble functional RNA genes but are not themselves expressed or do not yield functionally relevant transcripts or proteins. The human genome contains hundreds of U6 snRNA-related pseudogenes, most of which are not known to have functional roles, are not expressed, and do not participate in canonical RNA biology or disease processes[4]. There is no evidence that RNU6-494P produces a functional RNA, nor is it considered a therapeutic target, nor does it play a role in known pathologies or in drug mechanisms. It is included as a part of the non-coding RNA pseudogene repertoire cataloged in the reference human genome for genomic annotation and evolutionary studies[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 494, pseudogene (RNU6-494P).